Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Classement en actions #18727
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Prix de l'action
$2.35
Capitalisation boursière
$4.22M
Changement (1 jour)
-5.69%
Changement (1 an)
838.98%
Pays
MY
Échange BioNexus Gene Lab Corporation (BGLC)

Catégorie

Ratio P/B pour BioNexus Gene Lab Corporation (BGLC)
Ratio P/B au March 2026 TTM : 0.59
Selon les derniers rapports financiers et le cours de l'action de BioNexus Gene Lab Corporation, le ratio cours/valeur comptable actuel (TTM) est 0.59. À la fin de 2023, le ratio P/B était de 0.95.
Historique du ratio P/B pour BioNexus Gene Lab Corporation de 2016 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
2026 (TTM) 0.59 -1.60%
2024 0.60 -36.56%
2023 0.95 -96.17%
2022 24.65 -51.50%
2021 50.81 49.46%
2020 34.00 -79.93%
2019 169.36 76.55%
2018 95.93 -94.47%
2017 1.74K -101.39%
2016 -125.28K 0.00%
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
3.2693 453.74%
US
2.522 327.17%
US
28.6291 4,749.10%
US
3.6303 514.89%
CN
4.5682 673.75%
US